Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML. Martelli MP, Rossi R, Venanzi A, Meggendorfer M, et al. Blood 2021;138:2696-2701.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Martelli MP, Rossi R, Venanzi A, Meggendorfer M, et al. Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML. Blood 2021;138:2696-2701.
PMID: 34343258